MultiPlan (MPLN) Soars 15.5%: Is Further Upside Left in the Stock?

MultiPlan Corporation (MPLN) - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days [1] - The stock price rallied 15.5% in the last trading session to close at $14.70, driven by notable trading volume [3] - The stock has gained 76.6% over the past four weeks [3] - The company is expected to post a quarterly loss of$ 2.33 per share, representing a year-over-year change of +2.9% [5] - Revenues are expected to be $236.74 million, down 3% from the year-ago quarter [5] - The recent price increase is attributed to investor optimism surrounding the company's decision to consolidate its cloud infrastructure on Oracle Cloud Infrastructure (OCI) as part of its digital transformation strategy [4] Medpace (MEDP) - The consensus EPS estimate for the upcoming report has increased by +0.9% over the past month to$ 2.97, representing a +20.7% change from the same period last year [2] - The stock closed the last trading session 0.3% higher at $352.01 [1] - Over the past month, the stock has returned 1.4% [1] Industry Context - MultiPlan belongs to the Zacks Medical Services industry [1] - Medpace is another stock in the same industry [1]